STROKE. I69.4
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of stroke by physician consciousness level 14 to 16 based on Four Score NIHSS score 5-15 (National Institutes of Health Stroke Scale) no TPA no aphasia (based on (NIHSS criteria, stable vital signs) systolic blood pressure above 90 mmHg, heart rate above 40 and oxygen saturation above 94%) absence of significant fractures and orthopedic defects in organs absence of acute coronary syndrome respiratory failure or heart failure based on hospital records absence of conditions life-threatening such as having cardiac arrhythmia or receiving inotrope drugs (dopamine, dobuitamin) absence of restriction of movement so that the participant can raise his hand to the table paresis or unilateral body paralysis inactive range of motion at least 90 degrees for abduction shoulder and elbow flexion and 30 degrees for the wrist
Exclusion criteria
Exclusion criteria: Overt heart disease such as heart failure, angina pectoris, myocardial infarction within 120 days prior to the intervention, cardiomyopathy, or severe cardiac arrhythmia inflammation or infection muscular dystrophy, myasthenia gravis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BALANCE. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention. Method of measurement: through a questionnaire.;MORITCITY AND MOBILBITY. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention. Method of measurement: through a questionnaire.;TRUNK CONTROL. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention. Method of measurement: through a questionnaire.;Ability to perform daily tasks. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention. Method of measurement: through a questionnaire.;Electrolytic changes. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention. Method of measurement: through blood sample analysis.;Ischemic lesion volume and cognitive status. Timepoint: Before the intervention and 1, 2, 3, 4 weeks after the intervention: for the cognitive status and size of the lesion before and after the last intervention. Method of measurement: Through a questionnaire: cognitive status and examination of patients' scans: the size of the lesion. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences